Marc Davis is the the editor of, a digital resource for investors who follow Canada’s top-flight medical marijuana stocks.

In this interview, Marc talks to Bin Huang, PhD, MBA, who is the President and CEO of Emerald Health Therapeutics (TSX.V: EMH).

Her company is a pioneer in the race to develop pharmaceutical-grade medicinal formulas from the cannabis plant to address chronic pain and sleep disorders. To this end, the company has a strong science-driven focus.

Click here to read the entire article


Article by: Marc Davis on Stockhouse.